IJR News — today's news from every side

IJR News — today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Genius — OpenServe

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

OpenServe Drive OpenServe Inbox OpenServe Write OpenServe Studio OpenServe Projects OpenServe Focus OpenServe Mindmaps Teams OpenServe CRM Site Builder Whiteboard

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Popular
Elections

Genius — OpenServe

Burberry reworks signature check with Birtwell florals for 2027 show — Sep 21, 2026Celia Birtwell, 85, redrew Burberry's check into gingham and stripe with florals and faces for Daniel Lee's SS27 show that closed London Fashion Week.

+2

Dana Whitfield It's clever how they turned the gingham and stripes into something new while keeping the Burberry identity intact.

Argenx FB102 meets Phase 2 celiac endpointHealth — 1dArgenx Phase 2 FB102 trial in 126 celiac adults met the primary endpoint (Vh:Cd p=0.0176); firm plans Phase 3. Same day it halted the Sjögren's UNITY study.

0

Nationwide Recall Targets Gluten-Free Mixes Over Wheat Gluten — Sep 21, 2026GF Blends is recalling three gluten-free mixes—Truly AIP All Purpose Flour, Truly AIP Bread Mix, and EAT G.A.N.G.S.T.E.R. Flat Bread Pizza Mix—after independent testing found gluten in plantain flour supplied by PMF Global, potentially exposing people with celiac disease or severe gluten intolerance to adverse health effects. The recalled products were sold nationwide online and through retailers, and consumers should discard them or return for a full refund, with the company arranging replacements and providing contact information for questions; no illnesses have been reported to date.

0

Uvalde Shooter’s Grandma, 66, Triumphs Over Death After Being Shot, Instantly Reminds World What He Did to HerReporting — Jun 30, 2022For days, the world thought she was dead — the first of the many that would die on a May day that scarred the community of Uvalde, Texas, forever. But Celia Gonzales, the first person shot by her grandson Salvador Ramos…

0

IJRSchool District Says It Passed Audit With ‘Flying Colors.’ The Actual Report Tells A Different StoryParis Apodaca · 4 min · 1h

Argenx plans $2.2B Forte Biosciences deal — Jul 27, 2026Argenx has agreed to acquire Forte Biosciences for about $2.2 billion in cash, offering $77 per Forte share and funded entirely from Argenx’s cash to complete a Q3 2026 closing after standard approvals and tender conditions. The deal adds Forte’s FB102, a first-in-class CD122 antibody for vitiligo and celiac disease with potential broader autoimmune applications, boosting Argenx's immunology pipeline beyond Vyvgart.

0

Most Influential Women in World HistoryYourlist — RankingFrom ancient queens who ruled empires to modern activists who changed laws, these women left indelible marks on politics, science, and culture. Vote for who you think shaped history most profoundly.

Ascelia Completes FDA Meeting on OrviglanceHealth — Sep 8, 2026Biopharma firms report a mix of regulatory progress: Ascelia Pharma advances its Orviglance NDA with an FDA Type A meeting held and minutes due in about 30 days, while AstraZeneca secures FDA approval for Etcamah (camizestrant) after an advisory panel opposed it earlier, signaling a potential shift in benefit-risk assessment. Ascletis Pharma launches a US Phase I trial for ASC36 obesity drug under an IND, highlighting ongoing development in metabolism therapies alongside expectations of further data and pricing implications for investors.

0